Li CY - Search Results

1

Bone marrow effects of anagrelide therapy in patients with myelofibrosis with myeloid metaplasia.

Yoon SY, Li CY, Mesa RA, Tefferi A. Yoon SY, et al. Among authors: li cy. Br J Haematol. 1999 Sep;106(3):682-8. doi: 10.1046/j.1365-2141.1999.01598.x. Br J Haematol. 1999. PMID: 10468856 Free article.

2

2-Chlorodeoxyadenosine treatment after splenectomy in patients who have myelofibrosis with myeloid metaplasia.

Tefferi A, Silverstein MN, Li CY. Tefferi A, et al. Among authors: li cy. Br J Haematol. 1997 Nov;99(2):352-7. doi: 10.1046/j.1365-2141.1997.3843198.x. Br J Haematol. 1997. PMID: 9375753 Free article.

3

Bone marrow stromal cell distribution of basic fibroblast growth factor in chronic myeloid disorders.

Yoon SY, Tefferi A, Li CY. Yoon SY, et al. Among authors: li cy. Haematologica. 2001 Jan;86(1):52-7. Haematologica. 2001. PMID: 11146571

4

Bone marrow histochemical studies of fibrogenic cytokines and their receptors in myelodysplastic syndrome with myelofibrosis and related disorders.

Yoon SY, Li CY, Lloyd RV, Tefferi A. Yoon SY, et al. Among authors: li cy. Int J Hematol. 2000 Oct;72(3):337-42. Int J Hematol. 2000. PMID: 11185990

5

Cellular distribution of platelet-derived growth factor, transforming growth factor-beta, basic fibroblast growth factor, and their receptors in normal bone marrow.

Yoon SY, Tefferi A, Li CY. Yoon SY, et al. Among authors: li cy. Acta Haematol. 2000;104(4):151-7. doi: 10.1159/000046507. Acta Haematol. 2000. PMID: 11279303

6

Clinical correlates of splenic histopathology and splenic karyotype in myelofibrosis with myeloid metaplasia.

Mesa RA, Li CY, Schroeder G, Tefferi A. Mesa RA, et al. Among authors: li cy. Blood. 2001 Jun 1;97(11):3665-7. doi: 10.1182/blood.v97.11.3665. Blood. 2001. PMID: 11369668 Free article.

7

Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia.

Tefferi A, Mesa RA, Schroeder G, Hanson CA, Li CY, Dewald GW. Tefferi A, et al. Among authors: li cy. Br J Haematol. 2001 Jun;113(3):763-71. doi: 10.1046/j.1365-2141.2001.02796.x. Br J Haematol. 2001. PMID: 11380468 Free article.

8

A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), a novel anti-fibrosing agent, in myelofibrosis with myeloid metaplasia.

Mesa RA, Tefferi A, Elliott MA, Hoagland HC, Call TG, Schroeder GS, Yoon SY, Li CY, Gray LA, Margolin S, Hook CC. Mesa RA, et al. Among authors: li cy. Br J Haematol. 2001 Jul;114(1):111-3. doi: 10.1046/j.1365-2141.2001.02883.x. Br J Haematol. 2001. PMID: 11472354 Free article. Clinical Trial.

9

Monocytosis is an adverse prognostic factor for survival in younger patients with primary myelofibrosis.

Elliott MA, Verstovsek S, Dingli D, Schwager SM, Mesa RA, Li CY, Tefferi A. Elliott MA, et al. Among authors: li cy. Leuk Res. 2007 Nov;31(11):1503-9. doi: 10.1016/j.leukres.2006.12.025. Epub 2007 Mar 29. Leuk Res. 2007. PMID: 17397921

10

A phase II trial of tipifarnib in myelofibrosis: primary, post-polycythemia vera and post-essential thrombocythemia.

Mesa RA, Camoriano JK, Geyer SM, Wu W, Kaufmann SH, Rivera CE, Erlichman C, Wright J, Pardanani A, Lasho T, Finke C, Li CY, Tefferi A. Mesa RA, et al. Among authors: li cy. Leukemia. 2007 Sep;21(9):1964-70. doi: 10.1038/sj.leu.2404816. Epub 2007 Jun 21. Leukemia. 2007. PMID: 17581608 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,034 results

Search Page

Filters